Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009674
Filing Date
2025-05-12
Accepted
2025-05-12 16:05:35
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 699986
2 EX-31.1 ex31-1.htm EX-31.1 19325
3 EX-31.2 ex31-2.htm EX-31.2 19495
4 EX-32.1 ex32-1.htm EX-32.1 7141
5 EX-32.2 ex32-2.htm EX-32.2 7434
  Complete submission text file 0001641172-25-009674.txt   4701445

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xtnt-20250331.xsd EX-101.SCH 35926
7 XBRL CALCULATION FILE xtnt-20250331_cal.xml EX-101.CAL 65776
8 XBRL DEFINITION FILE xtnt-20250331_def.xml EX-101.DEF 145023
9 XBRL LABEL FILE xtnt-20250331_lab.xml EX-101.LAB 353315
10 XBRL PRESENTATION FILE xtnt-20250331_pre.xml EX-101.PRE 294545
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 554032
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 25934731
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)